Formulated for hypertension to manage systemic resistance and support blood pressure reduction.
Mechanism of Action
Azilsartan blocks angiotensin II receptors to prevent vasoconstriction. Chlorthalidone increases the renal excretion of sodium and water. This dual action targets both the pressure and volume components of hypertension.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
24 hours
Contraindications
Anuria, Pregnancy, Concurrent use of aliskiren in diabetics, Hypersensitivity to sulfonamides
Severe Adverse Events
Renal failure, Severe hypotension, Fetal toxicity — requires immediate medical attention
Information related to Azilsartan with Chlorthalidone is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
